These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37083958)

  • 21. Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Suanprasert N; Hanchaiphiboolkul S
    J Med Assoc Thai; 2017 Mar; 100(3):262-9. PubMed ID: 29911781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen JA; Bril V
    Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy.
    Hu N; Niu J; Liu M
    Neurol Sci; 2022 Oct; 43(10):5885-5898. PubMed ID: 35737187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
    Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
    Dionne A; Nicolle MW; Hahn AF
    Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inflammatory demyelinating polyradiculoneuropathy with autonomic involvement.
    Yamamoto K; Watarai M; Hashimoto T; Ikeda S
    Muscle Nerve; 2005 Jan; 31(1):108-12. PubMed ID: 15389651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenouse immunoglobuline in dysautonomia.
    Gavrilova N; Kamaeva E; Ignatova M; Ryabkova V; Lukashenko M; Soprun L; Churilov LP; Shoenfeld Y
    Clin Immunol; 2022 Jul; 240():109039. PubMed ID: 35569781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
    Eftimov F; van Schaik I
    Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.
    Ramchandren S; Lewis RA
    Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
    Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
    BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
    J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers of CIDP in patients with diabetes or CMT1.
    Latov N
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
    Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody.
    Doneddu PE; Ruiz M; Bianchi E; Liberatore G; Manganelli F; Cocito D; Cosentino G; Benedetti L; Marfia GA; Filosto M; Briani C; Giannotta C; Nobile-Orazio E
    Eur J Neurol; 2023 Feb; 30(2):501-510. PubMed ID: 35191144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
    Viala K
    Int J Neurosci; 2016 Sep; 126(9):777-85. PubMed ID: 26392214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.